WFA
IDXX icon

Wipfli Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

Wipfli Financial Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$269K Buy
+827
New +$304K 0.02% 357

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Wipfli Financial Advisors's IDXX Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Idexx Laboratories (IDXX) in Q3 2022: 827 shares worth $269K. The stake represents 0.02% of the portfolio and ranks #357 among its holdings.

924 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

  • Wipfli Financial Advisors held 827 shares of Idexx Laboratories worth $269K as of Q3 2022.
  • Idexx Laboratories was a new Wipfli Financial Advisors position in Q3 2022.
  • Idexx Laboratories made up 0.02% of Wipfli Financial Advisors's portfolio in Q3 2022, its #357 holding.
  • 924 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.